Outlook Therapeutics, Inc. - Common Stock, par value $0.01 per share (OTLK)
CUSIP: 69012T305
Q1 2026 13F Holders as of 31 Mar 2026
- Type / Class
- Equity / Common Stock, par value $0.01 per share
- Shares outstanding
- 120,049,038
- Total 13F shares
- 3,759,081
- Share change
- +750,794
- Total reported value
- $773,866
- Price per share
- $0.21
- Number of holders
- 20
- Value change
- +$29,440
- Number of buys
- 10
- Number of sells
- 6
Quarterly Holders Quick Answers
What is CUSIP 69012T305?
CUSIP 69012T305 identifies OTLK - Outlook Therapeutics, Inc. - Common Stock, par value $0.01 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
- Previous quarter: Q4 2025
Recent filing periods for CUSIP 69012T305:
Top shareholders of OTLK - Outlook Therapeutics, Inc. - Common Stock, par value $0.01 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| GMS Ventures & Investments |
13D/G
|
— |
50%
|
29,040,929
|
$45,303,849 | +$20,057,142 | 27 May 2025 | |
| Arun Kumar Pillai |
3/4/5
|
Director, 10%+ Owner |
—
class O/S missing
|
22,982,529
|
$26,085,170 | — | 01 Feb 2022 | |
| Tenshi Healthcare Pte. Ltd. |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
22,982,529
|
$26,085,170 | — | 21 Apr 2022 | |
| Sukhtian Ghiath M. |
3/4/5
|
Director, 10%+ Owner |
—
mixed-class rows
|
22,123,787
mixed-class rows
|
$18,973,302 | — | 27 May 2025 | |
| SPHERA FUNDS MANAGEMENT LTD. |
13D/G
|
— |
4.7%
|
3,153,856
|
$4,983,092 | +$920,239 | 31 Dec 2025 | |
| GREAT POINT PARTNERS LLC |
13D/G
|
— |
5%
|
2,220,000
|
$4,484,400 | $0 | 30 Jun 2025 | |
| Schonfeld Strategic Advisors LLC |
13F
|
Company |
2%
|
2,441,355
|
$3,857,338 | — | 31 Dec 2025 | |
| TANG CAPITAL MANAGEMENT LLC |
13D/G
|
— |
3.4%
|
1,500,000
|
$3,030,000 | -$808,000 | 30 Jun 2025 | |
| TANG CAPITAL PARTNERS LP |
13D/G
|
TANG CAPITAL MANAGEMENT, LLC |
6.4%
|
1,682,502
|
$2,624,703 | $0 | 31 Dec 2024 | |
| Empery Asset Management, LP |
13D/G
|
— |
5%
|
2,332,948
|
$2,472,925 | -$914,455 | 30 Sep 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
1.2%
|
1,465,167
|
$2,314,964 | — | 31 Dec 2025 | |
| Terry Dagnon |
3/4/5
|
Chief Operations Officer |
—
mixed-class rows
|
845,201
mixed-class rows
|
$741,221 | — | 20 Apr 2023 | |
| Syntone Ventures LLC |
3/4/5
|
10%+ Owner |
—
mixed-class rows
|
2,776,867
mixed-class rows
|
$716,284 | — | 15 Apr 2024 | |
| BlackRock, Inc. |
13F
|
Company |
0.34%
|
404,542
|
$639,177 | — | 31 Dec 2025 | |
| GILPIN WEALTH MANAGEMENT, LLC |
13F
|
Company |
0.3%
|
354,200
|
$559,636 | — | 31 Dec 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.26%
|
316,464
|
$500,120 | — | 31 Dec 2025 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.25%
|
298,456
|
$471,560 | — | 31 Dec 2025 | |
| Jeff Evanson |
3/4/5
|
CHIEF COMMERCIAL OFFICER |
—
mixed-class rows
|
833,459
mixed-class rows
|
$339,553 | — | 20 Mar 2024 | |
| UBS Group AG |
13F
|
Company |
0.17%
|
209,540
|
$331,073 | — | 31 Dec 2025 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.14%
|
172,022
|
$271,795 | — | 31 Dec 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.14%
|
164,498
|
$259,907 | — | 31 Dec 2025 | |
| STATE STREET CORP |
13F
|
Company |
0.14%
|
163,102
|
$257,701 | — | 31 Dec 2025 | |
| COMMONWEALTH EQUITY SERVICES, LLC |
13F
|
Company |
0.09%
|
112,500
|
$177,750 | — | 31 Dec 2025 | |
| SIMPLEX TRADING, LLC |
13F
|
Company |
0.09%
|
105,797
|
$167,159 | — | 31 Dec 2025 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.09%
|
104,662
|
$165,366 | — | 31 Dec 2025 | |
| SCOTIA CAPITAL INC. |
13F
|
Company |
0.06%
|
73,989
|
$116,903 | — | 31 Dec 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.06%
|
67,390
|
$106,476 | — | 31 Dec 2025 | |
| LVW Advisors, LLC |
13F
|
Company |
0.04%
|
48,235
|
$76,212 | — | 31 Dec 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.04%
|
45,782
|
$72,336 | — | 31 Dec 2025 | |
| Vontobel Holding Ltd. |
13F
|
Company |
0.03%
|
40,000
|
$63,200 | — | 31 Dec 2025 | |
| GROUP ONE TRADING LLC |
13F
|
Company |
0.03%
|
36,997
|
$58,455 | — | 31 Dec 2025 | |
| XTX Topco Ltd |
13F
|
Company |
0.03%
|
30,224
|
$47,754 | — | 31 Dec 2025 | |
| Christensen, King & Associates Investment Services, Inc. |
13F
|
Company |
0.02%
|
28,327
|
$44,757 | — | 31 Dec 2025 | |
| LPL Financial LLC |
13F
|
Company |
0.02%
|
21,794
|
$34,435 | — | 31 Dec 2025 | |
| Lawrence A. Kenyon |
3/4/5
|
Chief Financial Officer, Director |
—
mixed-class rows
|
18,446
mixed-class rows
|
$33,828 | — | 26 Sep 2024 | |
| Flower City Capital |
13F
|
Company |
0.02%
|
20,000
|
$31,600 | — | 31 Dec 2025 | |
| Vanguard Personalized Indexing Management, LLC |
13F
|
Company |
0.01%
|
15,605
|
$24,656 | — | 31 Dec 2025 | |
| PNC FINANCIAL SERVICES GROUP, INC. |
13F
|
Company |
0.01%
|
15,000
|
$23,700 | — | 31 Dec 2025 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.01%
|
12,873
|
$20,339 | — | 31 Dec 2025 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.01%
|
11,699
|
$18,484 | — | 31 Dec 2025 | |
| HARBOUR INVESTMENTS, INC. |
13F
|
Company |
0.01%
|
10,152
|
$16,040 | — | 31 Dec 2025 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0.01%
|
8,973
|
$14,175 | — | 31 Dec 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.01%
|
6,024
|
$9,518 | — | 31 Dec 2025 | |
| JONES FINANCIAL COMPANIES LLLP |
13F
|
Company |
0%
|
2,500
|
$3,950 | — | 31 Dec 2025 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
2,480
|
$3,918 | — | 31 Dec 2025 | |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO |
13F
|
Company |
0%
|
2,125
|
$3,358 | — | 31 Dec 2025 | |
| CITIGROUP INC |
13F
|
Company |
0%
|
1,554
|
$2,455 | — | 31 Dec 2025 | |
| Federation Des Caisses Desjardins du Quebec |
13F
|
Individual |
0%
|
1,312
|
$2,073 | — | 31 Dec 2025 | |
| Ancora Advisors LLC |
13F
|
Company |
0%
|
1,100
|
$1,738 | — | 31 Dec 2025 | |
| INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC |
13F
|
Company |
0%
|
1,000
|
$1,580 | — | 31 Dec 2025 |
Institutional Holders of Outlook Therapeutics, Inc. - Common Stock, par value $0.01 per share (OTLK) as of Q1 2026
As of 31 Mar 2026,
Outlook Therapeutics, Inc. - Common Stock, par value $0.01 per share (OTLK) was held by
20 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
3,759,081 shares.
The largest 10 holders included
VANGUARD CAPITAL MANAGEMENT LLC, GILPIN WEALTH MANAGEMENT, LLC, COMMONWEALTH EQUITY SERVICES, LLC, Warberg Asset Management LLC, VANGUARD FIDUCIARY TRUST CO, UBS Group AG, LPL Financial LLC, Christensen, King & Associates Investment Services, Inc., PNC FINANCIAL SERVICES GROUP, INC., and Flower City Capital.
This page lists
21
institutional shareholders reporting positions in this security
for the Q1 2026 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2026 vs Q4 2025 Across Filers
Q4 2025 holders
52
Q1 2026 holders
20
Holder diff
-32
| Investor | Q4 2025 Shares | Q1 2026 Shares | Share Diff | Share Chg % | Q4 2025 Value $ | Q1 2026 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.